Pink Sheet Podcast: Cell Therapy Enforcement Discretion Ends, Inspection Normalcy, FDA Hiring Boom

Pink Sheet reporters and editors discuss the end of stem cell clinic enforcement discretion, the US FDA’s projection that inspections will return to normal levels in FY 2022, and improved hiring in CDER.